Shopping cart

close

No products in the cart.

  • Menu
  • Home
  • About
    • Back
    • Who We Are
    • Foresights For Life
  • Products
    • Back
    • BELTEST-IT COV-2
    • BELTEST-IT AGS COV-2
    • BELTEST-IT CARDIO
    • BELTEST-IT DIA
    • BELTEST-IT FIBRO
    • TIKI MEDICAL
  • Shop
  • News
  • Contact
Pharmact GmbH
DEEN
Pharmact GmbH
  • Home
  • About
    • Who We Are
    • Foresights For Life
  • Products
    • Infectious Diseases

      BELTEST-IT AGS COV-2
      Antigen-Sputumtest
      BELTEST-IT COV-2
      Antibody Rapid Test

      Endocrine Diseases

      BELTEST-IT DIA
      Rapid Test

      Hepatic Diseases

      BELTEST-IT FIBRO
      Rapid Test

      Cardiovascular Diseases

      BELTEST-IT CARDIO
      Rapid Test

      Infection Protection

      TIKI MEDICAL
      Respiratory Protection Mask
  • Shop
  • News
  • Contact
  • My Account
  • 0/0,00 €

BELTEST-IT DIA

The BELTEST-IT DIA Rapid Test is intended to detect intact proinsulin in whole blood (fingerstick or venous), plasma, or serum. Measurements of intact proinsulin may be used in the diagnosis and treatment of patients who may develop future abnormal insulin secretion, including diabetes mellitus.*

PRODUCT INFORMATION

MethodImmunochromatographic assay
Sample TypeHuman whole blood (venipuncture and/or fingerstick), plasma, serum
Sample Size50 μL
Time to Results20 minutes
Storage Conditions2°C to 30°C (35°F to 86°F)
Shelf Life12 months

KIT CONTENTS

  • Test cassette

  • Pipette for transferring blood from the fingertip to the test cassette

  • Desiccant packet

  • Lancet

  • Vial containing buffer solution

  • Plastic bag for disposal of used test materials

  • Pouch with label

  • Instructions for use

TEST PERFORMANCE

BIOMARKER: Intact Proinsulin

SENSITIVITY

89.9%

SPECIFICITY

91.0%

ACCURACY

90.7%

*NOTE: Results from this test should not be used as the sole basis to diagnose or exclude endocrine disease. As with all diagnostic assays, the results obtained with this test must only be used as an adjunct to other information available to the healthcare professional. Treatment of patients should be based on a combination of symptoms, clinical signs, medical history, other laboratory tests and therapeutic responses.
Pharmact
Subscribe

Email Alerts


Thank you for subscribing!

Please check your inbox.

  • Privacy Policy
  • Terms and Conditions
  • Cancellation Policy
  • Imprint

Copyright ©2023 Pharmact GmbH. All rights reserved.